These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22799143)

  • 1. [Evolution of antipsychotics and their use in the treatment of schizophrenia. What's up, doc?].
    Jufe GS
    Vertex; 2011; 22(100):423-9. PubMed ID: 22799143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The trend for megadose polypharmacy in antipsychotic pharmacotherapy: a prescription survey conducted by the psychiatric clinical pharmacy research group].
    Yoshio T
    Seishin Shinkeigaku Zasshi; 2012; 114(6):690-5. PubMed ID: 22844820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
    Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
    Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics in the managed care era.
    Loebel AD; Botts SR; Feldman BI
    Am J Manag Care; 1998 Jan; 4 Suppl():S37-50; quiz S51-2. PubMed ID: 10181074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influences of second generation antipsychotics on the course of schizophrenia].
    Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S161-3. PubMed ID: 15570540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antipsychotic prescribing practices in an urban community mental health clinic.
    Monshat K; Carty B; Olver J; Castle D; Bosanac P
    Australas Psychiatry; 2010 Jun; 18(3):238-41. PubMed ID: 20482426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
    Meltzer HY; Davidson M; Glassman AH; Vieweg WV
    J Clin Psychiatry; 2002; 63 Suppl 9():25-9. PubMed ID: 12088173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of schizophrenia.
    Gadelha A; Noto CS; de Jesus Mari J
    Int Rev Psychiatry; 2012 Oct; 24(5):489-98. PubMed ID: 23057985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009.
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Shinfuku N; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Dixon LB; Kreyenbuhl JA; Tan CH
    Aust N Z J Psychiatry; 2011 Nov; 45(11):968-75. PubMed ID: 21888603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
    Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
    Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
    Kilian R; Dietrich S; Toumi M; Angermeyer MC
    Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of schizophrenia: ploypharmacy approaches.
    Rahiminejad F; Akhondzadeh S
    Acta Med Iran; 2010; 48(4):203-8. PubMed ID: 21279929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.